We are excited to announce that last month our online patient-recruitment platform iConnect 2.0 went live with CenterWatch. Clinical trials professionals as well as patients trust CenterWatch to get any information related to clinical trials. It has been a reliable source and global destination for...
Two radically new gene based immunotherapies were approved by the FDA this year - Kymriah followed by Yescarta - in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) - it was known as CTL019. Kymriah was approved for treatment...
TrialX is excited to participate and present in AMIA 2017, the 41st anniversary of the annual symposia conducted by the American Medical Informatics Association (AMIA). Every year, leading informaticians such as - translational scientists, clinicians, computer scientists, nurse informaticians, clinical researchers, public health officials, and...
iConnect 2.0 is a specifically designed online platform that facilitates patient-recruitment for academic medical centers, sponsors, and patient advocacy groups. iConnect 2.0 helps overcome challenges of patient recruitment in clinical trials by: Creating a centralized, up-to-date listing of trials within an organization using its Clinical Trial...
TrialX team had an exhilarating day on day1 of #DIA2017. Our CEO Sharib Khan, CTO Chintan Patel, creative director Aziz Rawat, and VP Clinical Trial Solutions Robert Ryan spent the day presenting our #patientengagement #patientrecruitment and #clinicaltrial solutions to the attendees at booth number 2513. This...
Patient centricity has not always been the focus of the healthcare industry. About a decade back the role of the patient in healthcare product development was not considered to be that important, with healthcare companies focussing only on science and technology as the stepping stones...
iConnect V.2 is about to be launched and we are very excited. Our team is working hard to meet timelines and bring to production enhanced features, UI changes and more. We mentioned how investigators can make their own flyers for their trials previously. This feature is...
